Dr. Kassem Bourgi, MD

Dr. Bourgi practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Bourgi's NPI, 1780948299, was assigned on June 28, 2012. Dr. Bourgi holds Tennessee license 71966.

Dr. Bourgi's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Bourgi's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Bourgi is also affiliated with Sidney & Lois Eskenazi Hospital. The medical group on file is Saint Joseph Medical Group. Dmand AI also links Dr. Bourgi to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bourgi practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Bourgi's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Bourgi's licenses on file in 3 states: Tennessee, Indiana and Michigan.

CMS data shows 267 Medicare services from Dr. Bourgi across 4 procedure codes in 2024, for 133 Medicare patients. Medicare paid $23,003 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 133 Medicare patients who saw Dr. Bourgi in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 41% are also on Medicaid. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bourgi's median patient age at 55, with 43% women.

In 2024, Dr. Bourgi wrote 122 Medicare Part D claims for 15 patients. 70% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $84,376 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

Dr. Bourgi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Bourgi, published from 2016 to 2023. 2016 was the busiest year, with 3. The most frequent topics are HIV Infections, HIV Integrase Inhibitors and Weight Gain. Dr. Bourgi has published most often in Clin Infect Dis. Dr. Bourgi's most frequent co-authors are John Robert Koethe, MD, Timothy M.d. Sterling, MD and Samir Gupta, MD.

CMS Open Payments shows 142 general payments to Dr. Bourgi from 6 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 57% of the total. Gilead Sciences, Inc. paid the most, $23,847. It also lists 12 research payments totaling $1,569 in 2019.